EVOK News and Press, Evoke Pharma Inc. From 08/08/19

Evoke Pharma (NASDAQ: EVOK ): Q2 GAAP EPS of -$0.09 beats by $0.03 . Cash and equivalents of $7.4M Press Release More news on: Evoke Pharma, Inc., Earnings news and commentary, Healthcare stocks news, ,

SOLANA BEACH, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that following receipt of U.S. Food and Drug Administration (FDA) minutes from a type A mee...

Turquoise Hill Resources TRQ  -31%  after Rio Tinto's Mongolia project expected to be delayed. More news on: China Lending Corporation, Adamis Pharmaceuticals Corporation, Workhorse Group Inc., Stocks on the move, Read more ...

SOLANA BEACH, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has submitted a type A meeting request and meeting package to the U.S. Food and Dru...

Evoke Pharma (NASDAQ: EVOK ): Q1 GAAP EPS of -$0.11 misses by $0.04. More news on: Evoke Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Projected cash runway extended to first quarter 2020 SOLANA BEACH, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the firs...

Gainers:  AVEO Pharmaceuticals (NASDAQ: AVEO ) +35% . ADMA Biologics (NASDAQ: ADMA ) +32% . Sangamo Therapeutics (NASDAQ: SGMO ) +27% . Castor Maritime (NASDAQ: CTRM ) +24% . EDAP TMS S.A. (NASDAQ: EDAP ) +23% . Riot Blockchain (NASDAQ: RIOT ) +22% . Vaccinex (NASDAQ: VCNX ) +1...

Energy Focus (NASDAQ: EFOI )  -52%  on Q4 earnings . More news on: Energy Focus, Inc., Evoke Pharma, Inc., Apyx Medical Corporation, Stocks on the move, Read more ...

Evoke Pharma (NASDAQ: EVOK ) has received a Complete Response Letter (CRL) from the FDA for its 505(b)(2) NDA for Gimoti for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. More news on: Evoke Pharma, Inc., Healthcare stocks news, Stocks on the mov...

SOLANA BEACH, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administ...